Latest News
GE HealthCare expands Vivid cardiovascular ultrasound portfolio with three new systems
28 August 2026 - Medical technology company GE HealthCare (Nasdaq:GEHC) on Friday unveiled three additions to its Vivid cardiovascular ultrasound portfolio: Vivid Explorer, Vivid Advanced and Vivid Focus, designed to address imaging and workflow need...
Daiichi Sankyo data highlight real-world impact of bempedoic acid on cardiovascular risk
28 August 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) said on Friday that new analyses from the multinational MILOS study demonstrate the real-world impact of bempedoic acid, used alone or in combination with ezetimibe, in man...
Zambon receives European Commission approval for Hopledo in Parkinson's disease
28 August 2026 - Italian pharmaceutical company Zambon announced on Friday that the European Commission has granted marketing authorisation for Hopledo, a first-in-class oral, modified-release formulation of levodopa/carbidopa for adults with Parkins...
Pfizer and BioNTech granted FDA approval for XFG-adapted COVID-19 vaccine
28 August 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) and German biotechnology company BioNTech SE (NASDAQ:BNTX) announced on Thursday that the US Food and Drug Administration (FDA) has approved their 2026-2027 COVID-19 vaccine formula ...
Kazia Therapeutics reports 100% clinical benefit rate in initial paxalisib breast cancer trial
28 August 2026 - Kazia Therapeutics Limited (NASDAQ:KZIA), an oncology-focused drug development company based in Sydney, Australia, announced on Thursday new data showing that its lead asset, paxalisib, achieved a 100% clinical benefit rate in six ev...